BDX
Becton, Dickinson and Company
NYSE · USHealthcareMedical - Instruments & Supplies
$154.48-2.33%
Price as of Jul 20, 2026
BDX valuation
Becton, Dickinson and Company valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 11.49x
- P/E 2026E
- 12.43x
- P/E 2027E
- 11.63x
- P/E 2028E
- 10.93x
- P/S forward
- 2.18x
Trailing multiples
- P/E TTM
- 39.11x
- PEG TTM
- 0.16x
- Price / book
- 1.76x
- Price / sales
- 1.99x
- Price / cash flow
- 10.91x
Enterprise value
- Enterprise value
- $59.0B
- EV / sales
- 2.76x
- EV / EBITDA
- 12.60x
- EV / EBIT
- 26.04x
- Market cap
- $42.6B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.